MORBIDITY AND MORTALITY WITHIN 30 DAYS OF SACT - REVIEW OF CURRENT PRACTICE - STANDARDISED REVIEW PROCESS

The importance of having mortality meetings to review deaths within 30 days of treatment with SACT has been established and most trusts have developed their own system for deciding which cases to discuss. The UK Chemotherapy Board recognised the many current examples of good practice but noted an inconsistency of approach between centres which may limit sharing of learning. It has summarised the key details of the processes currently used and developed a proposed template for an operational policy and pro forma.

 

Available for Download

Morbidity and mortality within 30 days of SACT therapy: review of current practice suggested standardised review process.

May 2016

Appendix 3: Proposed 30 day SACT mortality proforma

May 2016

30 day SACT mortality letter

May 2016

Download